HETEROCYCLICALLY SUBSTITUTED BENZOYLUREAS, METHOD FOR THEIR PRODUCTION AND THEIR USE AS MEDICAMENTS

Details for Australian Patent Application No. 2003249937 (hide)

Owner AVENTIS PHARMA DEUTSCHLAND GMBH

Inventors Herling, Andreas; Kadereit, Dieter; Defossa, Elisabeth; Klabunde, Thomas; Burger, Hans-Joerg; Schoenafinger, Karl; Wendt, Karl-Ulrich; Von Roedern, Erich

Agent Watermark

Pub. Number AU-A-2003249937

PCT Number PCT/EP03/07078

PCT Pub. Number WO2004/007455

Priority 102 31 627.9 12.07.02 DE; 103 06 503.2 17.02.03 DE; 103 20 326.5 06.05.03 DE

Filing date 3 July 2003

Wipo publication date 2 February 2004

International Classifications

C07D 211/62 Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

C07D 249/08 Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms

C07D 257/04 Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms

C07D 271/10 Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms

C07D 253/06 Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 231/26 Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

C07D 307/68 Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom

C07D 235/18 Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings

A61K 031/17 - having the group NC(O)N or NC(S)N, e.g. urea, thiourea, carmustine

A61P 003/10 Drugs for disorders of the metabolism

Event Publications

16 October 2003 Complete Application Filed

  Priority application(s): 102 31 627.9 12.07.02 DE; 103 06 503.2 17.02.03 DE; 103 20 326.5 06.05.03 DE

18 March 2004 Application Open to Public Inspection

  Published as AU-A-2003249937

22 December 2005 Assignment before Grant

  Aventis Pharma Deutschland GmbH The application has been assigned to Sanofi-Aventis Deutschland GmbH

26 July 2007 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003249938-METHOD FOR THE CONTINUOUS PRODUCTION OF TETRASUBSTITUTED UREAS

2003249936-SELF-ADHESIVE FILM COMPRISING AN ANTISKID COATING LAYER